CCR4 and hepatocellular carcinoma: TGF-β1, a critical molecule that participates in fibrosis progression and in HCC development, dropped significantly post CCR4 blockade, suggesting CCR4 as a critical target to control Tregs mediated immune suppression and progression of liver disease.